Neoplasia

Papers
(The H4-Index of Neoplasia is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
UALCAN: An update to the integrated cancer data analysis platform973
ONC201 and imipridones: Anti-cancer compounds with clinical efficacy101
Development and prevalence of castration-resistant prostate cancer subtypes83
ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma82
Glycolysis-induced drug resistance in tumors—A response to danger signals?58
STAT3 as a mediator of oncogenic cellular metabolism: Pathogenic and therapeutic implications58
Exosomal lncRNA NEAT1 from cancer-associated fibroblasts facilitates endometrial cancer progression via miR-26a/b-5p-mediated STAT3/YKL-40 signaling pathway52
The forces driving cancer extracellular vesicle secretion48
SalvGlandDx – a comprehensive salivary gland neoplasm specific next generation sequencing panel to facilitate diagnosis and identify therapeutic targets48
Evaluating patient-specific neoadjuvant regimens for breast cancer via a mathematical model constrained by quantitative magnetic resonance imaging data43
Rosmarinic acid represses colitis-associated colon cancer: A pivotal involvement of the TLR4-mediated NF-κB-STAT3 axis43
Tumor necrosis factor in lung cancer: Complex roles in biology and resistance to treatment41
Breast cancers, mammary stem cells, and cancer stem cells, characteristics, and hypotheses39
Pediatric low-grade glioma: Targeted therapeutics and clinical trials in the molecular era36
Short chain fatty acids delay the development of hepatocellular carcinoma in HBx transgenic mice36
Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine35
MiR-944/CISH mediated inflammation via STAT3 is involved in oral cancer malignance by cigarette smoking34
Quantifying ADC bystander payload penetration with cellular resolution using pharmacodynamic mapping34
The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science33
Trop‐2 cleavage by ADAM10 is an activator switch for cancer growth and metastasis33
Predicting patient-specific response to adaptive therapy in metastatic castration-resistant prostate cancer using prostate-specific antigen dynamics33
Bone marrow mesenchymal stem cells interact with head and neck squamous cell carcinoma cells to promote cancer progression and drug resistance30
Cholesterol and saturated fatty acids synergistically promote the malignant progression of prostate cancer29
Endogenous hydrogen sulfide regulates xCT stability through persulfidation of OTUB1 at cysteine 91 in colon cancer cells29
Opioids drive breast cancer metastasis through the δ-opioid receptor and oncogenic STAT328
Ultrasound-mediated disruption of the blood tumor barrier for improved therapeutic delivery27
EZH2i EPZ-6438 and HDACi vorinostat synergize with ONC201/TIC10 to activate integrated stress response, DR5, reduce H3K27 methylation, ClpX and promote apoptosis of multiple tumor types including DIPG27
0.038928985595703